Judge Postpones Hearing On Pfizer Bid To Block Neurontin Generic

Law360, New York (September 27, 2004, 12:00 AM EDT) -- A court hearing on a motion by drug maker Pfizer Inc. to bar Alpharma Inc. from rolling out a generic version of the Pfizer epilepsy drug Neurontin has been postponed until Oct. 1, Alpharma said on Monday.

Judge John C. Lifland of the U.S. District Court for the District of New Jersey denied a Pfizer request which would have prohibited an Alpharma launch until the date of a decision on the preliminary injunction.

Alpharma said it continues to “review its options regarding gabapentin, including a launch...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.